The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Asthma Therapeutic Drug Market Research Report 2025
Synopsis
The global Asthma Therapeutic Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Asthma Therapeutic Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Asthma Therapeutic Drug.
Report Scope
The Asthma Therapeutic Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Asthma Therapeutic Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Asthma Therapeutic Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Akorn
AbbVie
AstraZeneca
Boehringer Ingelheim
Cipla
GSK
Merck
Mylan
Novartis
Pfizer
Roche
Teva
Vectura
Segment by Type
Long-Term Control Medications
Quick-Relief Medications
Segment by Application
Online Pharmacy
Offline Pharmacy
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Asthma Therapeutic Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Asthma Therapeutic Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Asthma Therapeutic Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Asthma Therapeutic Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Asthma Therapeutic Drug.
Report Scope
The Asthma Therapeutic Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Asthma Therapeutic Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Asthma Therapeutic Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Akorn
AbbVie
AstraZeneca
Boehringer Ingelheim
Cipla
GSK
Merck
Mylan
Novartis
Pfizer
Roche
Teva
Vectura
Segment by Type
Long-Term Control Medications
Quick-Relief Medications
Segment by Application
Online Pharmacy
Offline Pharmacy
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Asthma Therapeutic Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Asthma Therapeutic Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Asthma Therapeutic Drug Market Overview
1.1 Product Overview and Scope of Asthma Therapeutic Drug
1.2 Asthma Therapeutic Drug Segment by Type
1.2.1 Global Asthma Therapeutic Drug Market Value Comparison by Type (2024-2030)
1.2.2 Long-Term Control Medications
1.2.3 Quick-Relief Medications
1.3 Asthma Therapeutic Drug Segment by Application
1.3.1 Global Asthma Therapeutic Drug Market Value by Application: (2024-2030)
1.3.2 Online Pharmacy
1.3.3 Offline Pharmacy
1.4 Global Asthma Therapeutic Drug Market Size Estimates and Forecasts
1.4.1 Global Asthma Therapeutic Drug Revenue 2019-2030
1.4.2 Global Asthma Therapeutic Drug Sales 2019-2030
1.4.3 Global Asthma Therapeutic Drug Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Asthma Therapeutic Drug Market Competition by Manufacturers
2.1 Global Asthma Therapeutic Drug Sales Market Share by Manufacturers (2019-2024)
2.2 Global Asthma Therapeutic Drug Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Asthma Therapeutic Drug Average Price by Manufacturers (2019-2024)
2.4 Global Asthma Therapeutic Drug Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Asthma Therapeutic Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Asthma Therapeutic Drug, Product Type & Application
2.7 Asthma Therapeutic Drug Market Competitive Situation and Trends
2.7.1 Asthma Therapeutic Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Asthma Therapeutic Drug Players Market Share by Revenue
2.7.3 Global Asthma Therapeutic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Asthma Therapeutic Drug Retrospective Market Scenario by Region
3.1 Global Asthma Therapeutic Drug Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Asthma Therapeutic Drug Global Asthma Therapeutic Drug Sales by Region: 2019-2030
3.2.1 Global Asthma Therapeutic Drug Sales by Region: 2019-2024
3.2.2 Global Asthma Therapeutic Drug Sales by Region: 2025-2030
3.3 Global Asthma Therapeutic Drug Global Asthma Therapeutic Drug Revenue by Region: 2019-2030
3.3.1 Global Asthma Therapeutic Drug Revenue by Region: 2019-2024
3.3.2 Global Asthma Therapeutic Drug Revenue by Region: 2025-2030
3.4 North America Asthma Therapeutic Drug Market Facts & Figures by Country
3.4.1 North America Asthma Therapeutic Drug Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Asthma Therapeutic Drug Sales by Country (2019-2030)
3.4.3 North America Asthma Therapeutic Drug Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Asthma Therapeutic Drug Market Facts & Figures by Country
3.5.1 Europe Asthma Therapeutic Drug Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Asthma Therapeutic Drug Sales by Country (2019-2030)
3.5.3 Europe Asthma Therapeutic Drug Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Asthma Therapeutic Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Asthma Therapeutic Drug Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Asthma Therapeutic Drug Sales by Country (2019-2030)
3.6.3 Asia Pacific Asthma Therapeutic Drug Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Asthma Therapeutic Drug Market Facts & Figures by Country
3.7.1 Latin America Asthma Therapeutic Drug Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Asthma Therapeutic Drug Sales by Country (2019-2030)
3.7.3 Latin America Asthma Therapeutic Drug Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Asthma Therapeutic Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Asthma Therapeutic Drug Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Asthma Therapeutic Drug Sales by Country (2019-2030)
3.8.3 Middle East and Africa Asthma Therapeutic Drug Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Asthma Therapeutic Drug Sales by Type (2019-2030)
4.1.1 Global Asthma Therapeutic Drug Sales by Type (2019-2024)
4.1.2 Global Asthma Therapeutic Drug Sales by Type (2025-2030)
4.1.3 Global Asthma Therapeutic Drug Sales Market Share by Type (2019-2030)
4.2 Global Asthma Therapeutic Drug Revenue by Type (2019-2030)
4.2.1 Global Asthma Therapeutic Drug Revenue by Type (2019-2024)
4.2.2 Global Asthma Therapeutic Drug Revenue by Type (2025-2030)
4.2.3 Global Asthma Therapeutic Drug Revenue Market Share by Type (2019-2030)
4.3 Global Asthma Therapeutic Drug Price by Type (2019-2030)
5 Segment by Application
5.1 Global Asthma Therapeutic Drug Sales by Application (2019-2030)
5.1.1 Global Asthma Therapeutic Drug Sales by Application (2019-2024)
5.1.2 Global Asthma Therapeutic Drug Sales by Application (2025-2030)
5.1.3 Global Asthma Therapeutic Drug Sales Market Share by Application (2019-2030)
5.2 Global Asthma Therapeutic Drug Revenue by Application (2019-2030)
5.2.1 Global Asthma Therapeutic Drug Revenue by Application (2019-2024)
5.2.2 Global Asthma Therapeutic Drug Revenue by Application (2025-2030)
5.2.3 Global Asthma Therapeutic Drug Revenue Market Share by Application (2019-2030)
5.3 Global Asthma Therapeutic Drug Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Corporation Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott Asthma Therapeutic Drug Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Abbott Asthma Therapeutic Drug Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Akorn
6.2.1 Akorn Corporation Information
6.2.2 Akorn Description and Business Overview
6.2.3 Akorn Asthma Therapeutic Drug Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Akorn Asthma Therapeutic Drug Product Portfolio
6.2.5 Akorn Recent Developments/Updates
6.3 AbbVie
6.3.1 AbbVie Corporation Information
6.3.2 AbbVie Description and Business Overview
6.3.3 AbbVie Asthma Therapeutic Drug Sales, Revenue and Gross Margin (2019-2024)
6.3.4 AbbVie Asthma Therapeutic Drug Product Portfolio
6.3.5 AbbVie Recent Developments/Updates
6.4 AstraZeneca
6.4.1 AstraZeneca Corporation Information
6.4.2 AstraZeneca Description and Business Overview
6.4.3 AstraZeneca Asthma Therapeutic Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 AstraZeneca Asthma Therapeutic Drug Product Portfolio
6.4.5 AstraZeneca Recent Developments/Updates
6.5 Boehringer Ingelheim
6.5.1 Boehringer Ingelheim Corporation Information
6.5.2 Boehringer Ingelheim Description and Business Overview
6.5.3 Boehringer Ingelheim Asthma Therapeutic Drug Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Boehringer Ingelheim Asthma Therapeutic Drug Product Portfolio
6.5.5 Boehringer Ingelheim Recent Developments/Updates
6.6 Cipla
6.6.1 Cipla Corporation Information
6.6.2 Cipla Description and Business Overview
6.6.3 Cipla Asthma Therapeutic Drug Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Cipla Asthma Therapeutic Drug Product Portfolio
6.6.5 Cipla Recent Developments/Updates
6.7 GSK
6.6.1 GSK Corporation Information
6.6.2 GSK Description and Business Overview
6.6.3 GSK Asthma Therapeutic Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 GSK Asthma Therapeutic Drug Product Portfolio
6.7.5 GSK Recent Developments/Updates
6.8 Merck
6.8.1 Merck Corporation Information
6.8.2 Merck Description and Business Overview
6.8.3 Merck Asthma Therapeutic Drug Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Merck Asthma Therapeutic Drug Product Portfolio
6.8.5 Merck Recent Developments/Updates
6.9 Mylan
6.9.1 Mylan Corporation Information
6.9.2 Mylan Description and Business Overview
6.9.3 Mylan Asthma Therapeutic Drug Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Mylan Asthma Therapeutic Drug Product Portfolio
6.9.5 Mylan Recent Developments/Updates
6.10 Novartis
6.10.1 Novartis Corporation Information
6.10.2 Novartis Description and Business Overview
6.10.3 Novartis Asthma Therapeutic Drug Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Novartis Asthma Therapeutic Drug Product Portfolio
6.10.5 Novartis Recent Developments/Updates
6.11 Pfizer
6.11.1 Pfizer Corporation Information
6.11.2 Pfizer Asthma Therapeutic Drug Description and Business Overview
6.11.3 Pfizer Asthma Therapeutic Drug Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Pfizer Asthma Therapeutic Drug Product Portfolio
6.11.5 Pfizer Recent Developments/Updates
6.12 Roche
6.12.1 Roche Corporation Information
6.12.2 Roche Asthma Therapeutic Drug Description and Business Overview
6.12.3 Roche Asthma Therapeutic Drug Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Roche Asthma Therapeutic Drug Product Portfolio
6.12.5 Roche Recent Developments/Updates
6.13 Teva
6.13.1 Teva Corporation Information
6.13.2 Teva Asthma Therapeutic Drug Description and Business Overview
6.13.3 Teva Asthma Therapeutic Drug Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Teva Asthma Therapeutic Drug Product Portfolio
6.13.5 Teva Recent Developments/Updates
6.14 Vectura
6.14.1 Vectura Corporation Information
6.14.2 Vectura Asthma Therapeutic Drug Description and Business Overview
6.14.3 Vectura Asthma Therapeutic Drug Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Vectura Asthma Therapeutic Drug Product Portfolio
6.14.5 Vectura Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Asthma Therapeutic Drug Industry Chain Analysis
7.2 Asthma Therapeutic Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Asthma Therapeutic Drug Production Mode & Process
7.4 Asthma Therapeutic Drug Sales and Marketing
7.4.1 Asthma Therapeutic Drug Sales Channels
7.4.2 Asthma Therapeutic Drug Distributors
7.5 Asthma Therapeutic Drug Customers
8 Asthma Therapeutic Drug Market Dynamics
8.1 Asthma Therapeutic Drug Industry Trends
8.2 Asthma Therapeutic Drug Market Drivers
8.3 Asthma Therapeutic Drug Market Challenges
8.4 Asthma Therapeutic Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Asthma Therapeutic Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Asthma Therapeutic Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Asthma Therapeutic Drug Market Competitive Situation by Manufacturers in 2023
Table 4. Global Asthma Therapeutic Drug Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Asthma Therapeutic Drug Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Asthma Therapeutic Drug Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Asthma Therapeutic Drug Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Asthma Therapeutic Drug Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Asthma Therapeutic Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Asthma Therapeutic Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Asthma Therapeutic Drug, Product Type & Application
Table 12. Global Key Manufacturers of Asthma Therapeutic Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Asthma Therapeutic Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Asthma Therapeutic Drug as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Asthma Therapeutic Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Asthma Therapeutic Drug Sales by Region (2019-2024) & (K Units)
Table 18. Global Asthma Therapeutic Drug Sales Market Share by Region (2019-2024)
Table 19. Global Asthma Therapeutic Drug Sales by Region (2025-2030) & (K Units)
Table 20. Global Asthma Therapeutic Drug Sales Market Share by Region (2025-2030)
Table 21. Global Asthma Therapeutic Drug Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Asthma Therapeutic Drug Revenue Market Share by Region (2019-2024)
Table 23. Global Asthma Therapeutic Drug Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Asthma Therapeutic Drug Revenue Market Share by Region (2025-2030)
Table 25. North America Asthma Therapeutic Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Asthma Therapeutic Drug Sales by Country (2019-2024) & (K Units)
Table 27. North America Asthma Therapeutic Drug Sales by Country (2025-2030) & (K Units)
Table 28. North America Asthma Therapeutic Drug Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Asthma Therapeutic Drug Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Asthma Therapeutic Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Asthma Therapeutic Drug Sales by Country (2019-2024) & (K Units)
Table 32. Europe Asthma Therapeutic Drug Sales by Country (2025-2030) & (K Units)
Table 33. Europe Asthma Therapeutic Drug Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Asthma Therapeutic Drug Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Asthma Therapeutic Drug Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Asthma Therapeutic Drug Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Asthma Therapeutic Drug Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Asthma Therapeutic Drug Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Asthma Therapeutic Drug Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Asthma Therapeutic Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Asthma Therapeutic Drug Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Asthma Therapeutic Drug Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Asthma Therapeutic Drug Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Asthma Therapeutic Drug Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Asthma Therapeutic Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Asthma Therapeutic Drug Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Asthma Therapeutic Drug Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Asthma Therapeutic Drug Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Asthma Therapeutic Drug Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Asthma Therapeutic Drug Sales (K Units) by Type (2019-2024)
Table 51. Global Asthma Therapeutic Drug Sales (K Units) by Type (2025-2030)
Table 52. Global Asthma Therapeutic Drug Sales Market Share by Type (2019-2024)
Table 53. Global Asthma Therapeutic Drug Sales Market Share by Type (2025-2030)
Table 54. Global Asthma Therapeutic Drug Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Asthma Therapeutic Drug Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Asthma Therapeutic Drug Revenue Market Share by Type (2019-2024)
Table 57. Global Asthma Therapeutic Drug Revenue Market Share by Type (2025-2030)
Table 58. Global Asthma Therapeutic Drug Price (US$/Unit) by Type (2019-2024)
Table 59. Global Asthma Therapeutic Drug Price (US$/Unit) by Type (2025-2030)
Table 60. Global Asthma Therapeutic Drug Sales (K Units) by Application (2019-2024)
Table 61. Global Asthma Therapeutic Drug Sales (K Units) by Application (2025-2030)
Table 62. Global Asthma Therapeutic Drug Sales Market Share by Application (2019-2024)
Table 63. Global Asthma Therapeutic Drug Sales Market Share by Application (2025-2030)
Table 64. Global Asthma Therapeutic Drug Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Asthma Therapeutic Drug Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Asthma Therapeutic Drug Revenue Market Share by Application (2019-2024)
Table 67. Global Asthma Therapeutic Drug Revenue Market Share by Application (2025-2030)
Table 68. Global Asthma Therapeutic Drug Price (US$/Unit) by Application (2019-2024)
Table 69. Global Asthma Therapeutic Drug Price (US$/Unit) by Application (2025-2030)
Table 70. Abbott Corporation Information
Table 71. Abbott Description and Business Overview
Table 72. Abbott Asthma Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Abbott Asthma Therapeutic Drug Product
Table 74. Abbott Recent Developments/Updates
Table 75. Akorn Corporation Information
Table 76. Akorn Description and Business Overview
Table 77. Akorn Asthma Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Akorn Asthma Therapeutic Drug Product
Table 79. Akorn Recent Developments/Updates
Table 80. AbbVie Corporation Information
Table 81. AbbVie Description and Business Overview
Table 82. AbbVie Asthma Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. AbbVie Asthma Therapeutic Drug Product
Table 84. AbbVie Recent Developments/Updates
Table 85. AstraZeneca Corporation Information
Table 86. AstraZeneca Description and Business Overview
Table 87. AstraZeneca Asthma Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. AstraZeneca Asthma Therapeutic Drug Product
Table 89. AstraZeneca Recent Developments/Updates
Table 90. Boehringer Ingelheim Corporation Information
Table 91. Boehringer Ingelheim Description and Business Overview
Table 92. Boehringer Ingelheim Asthma Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Boehringer Ingelheim Asthma Therapeutic Drug Product
Table 94. Boehringer Ingelheim Recent Developments/Updates
Table 95. Cipla Corporation Information
Table 96. Cipla Description and Business Overview
Table 97. Cipla Asthma Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Cipla Asthma Therapeutic Drug Product
Table 99. Cipla Recent Developments/Updates
Table 100. GSK Corporation Information
Table 101. GSK Description and Business Overview
Table 102. GSK Asthma Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. GSK Asthma Therapeutic Drug Product
Table 104. GSK Recent Developments/Updates
Table 105. Merck Corporation Information
Table 106. Merck Description and Business Overview
Table 107. Merck Asthma Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Merck Asthma Therapeutic Drug Product
Table 109. Merck Recent Developments/Updates
Table 110. Mylan Corporation Information
Table 111. Mylan Description and Business Overview
Table 112. Mylan Asthma Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Mylan Asthma Therapeutic Drug Product
Table 114. Mylan Recent Developments/Updates
Table 115. Novartis Corporation Information
Table 116. Novartis Description and Business Overview
Table 117. Novartis Asthma Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Novartis Asthma Therapeutic Drug Product
Table 119. Novartis Recent Developments/Updates
Table 120. Pfizer Corporation Information
Table 121. Pfizer Description and Business Overview
Table 122. Pfizer Asthma Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Pfizer Asthma Therapeutic Drug Product
Table 124. Pfizer Recent Developments/Updates
Table 125. Roche Corporation Information
Table 126. Roche Description and Business Overview
Table 127. Roche Asthma Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Roche Asthma Therapeutic Drug Product
Table 129. Roche Recent Developments/Updates
Table 130. Teva Corporation Information
Table 131. Teva Description and Business Overview
Table 132. Teva Asthma Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Teva Asthma Therapeutic Drug Product
Table 134. Teva Recent Developments/Updates
Table 135. Vectura Corporation Information
Table 136. Vectura Description and Business Overview
Table 137. Vectura Asthma Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Vectura Asthma Therapeutic Drug Product
Table 139. Vectura Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Asthma Therapeutic Drug Distributors List
Table 143. Asthma Therapeutic Drug Customers List
Table 144. Asthma Therapeutic Drug Market Trends
Table 145. Asthma Therapeutic Drug Market Drivers
Table 146. Asthma Therapeutic Drug Market Challenges
Table 147. Asthma Therapeutic Drug Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Asthma Therapeutic Drug
Figure 2. Global Asthma Therapeutic Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Asthma Therapeutic Drug Market Share by Type in 2023 & 2030
Figure 4. Long-Term Control Medications Product Picture
Figure 5. Quick-Relief Medications Product Picture
Figure 6. Global Asthma Therapeutic Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Asthma Therapeutic Drug Market Share by Application in 2023 & 2030
Figure 8. Online Pharmacy
Figure 9. Offline Pharmacy
Figure 10. Global Asthma Therapeutic Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Asthma Therapeutic Drug Market Size (2019-2030) & (US$ Million)
Figure 12. Global Asthma Therapeutic Drug Sales (2019-2030) & (K Units)
Figure 13. Global Asthma Therapeutic Drug Average Price (US$/Unit) & (2019-2030)
Figure 14. Asthma Therapeutic Drug Report Years Considered
Figure 15. Asthma Therapeutic Drug Sales Share by Manufacturers in 2023
Figure 16. Global Asthma Therapeutic Drug Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Asthma Therapeutic Drug Players: Market Share by Revenue in 2023
Figure 18. Asthma Therapeutic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Asthma Therapeutic Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Asthma Therapeutic Drug Sales Market Share by Country (2019-2030)
Figure 21. North America Asthma Therapeutic Drug Revenue Market Share by Country (2019-2030)
Figure 22. United States Asthma Therapeutic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Asthma Therapeutic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Asthma Therapeutic Drug Sales Market Share by Country (2019-2030)
Figure 25. Europe Asthma Therapeutic Drug Revenue Market Share by Country (2019-2030)
Figure 26. Germany Asthma Therapeutic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Asthma Therapeutic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Asthma Therapeutic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Asthma Therapeutic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia Asthma Therapeutic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Asthma Therapeutic Drug Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Asthma Therapeutic Drug Revenue Market Share by Region (2019-2030)
Figure 33. China Asthma Therapeutic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Asthma Therapeutic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Asthma Therapeutic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Asthma Therapeutic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia Asthma Therapeutic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. China Taiwan Asthma Therapeutic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Indonesia Asthma Therapeutic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Thailand Asthma Therapeutic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Malaysia Asthma Therapeutic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Latin America Asthma Therapeutic Drug Sales Market Share by Country (2019-2030)
Figure 43. Latin America Asthma Therapeutic Drug Revenue Market Share by Country (2019-2030)
Figure 44. Mexico Asthma Therapeutic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Brazil Asthma Therapeutic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Argentina Asthma Therapeutic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Asthma Therapeutic Drug Sales Market Share by Country (2019-2030)
Figure 48. Middle East & Africa Asthma Therapeutic Drug Revenue Market Share by Country (2019-2030)
Figure 49. Turkey Asthma Therapeutic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Asthma Therapeutic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. UAE Asthma Therapeutic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Global Sales Market Share of Asthma Therapeutic Drug by Type (2019-2030)
Figure 53. Global Revenue Market Share of Asthma Therapeutic Drug by Type (2019-2030)
Figure 54. Global Asthma Therapeutic Drug Price (US$/Unit) by Type (2019-2030)
Figure 55. Global Sales Market Share of Asthma Therapeutic Drug by Application (2019-2030)
Figure 56. Global Revenue Market Share of Asthma Therapeutic Drug by Application (2019-2030)
Figure 57. Global Asthma Therapeutic Drug Price (US$/Unit) by Application (2019-2030)
Figure 58. Asthma Therapeutic Drug Value Chain
Figure 59. Asthma Therapeutic Drug Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
